Literature DB >> 30326728

Might Brushed Nasal Cells Be a Surrogate for CFTR Modulator Clinical Response?

Iwona Pranke1, Aurelie Hatton1, Alexandra Masson2,3, Thomas Flament4, Muriel Le Bourgeois2, Frederique Chedevergne2, Celine Bailly2, Valerie Urbach1, Alexandre Hinzpeter1, Aleksander Edelman1, Isabelle Sermet-Gaudelus1,2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30326728     DOI： 10.1164/rccm.201808-1436LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  13 in total

Review 1.  CFTR and Gastrointestinal Cancers: An Update.

Authors:  Rahul Bhattacharya; Zachary Blankenheim; Patricia M Scott; Robert T Cormier
Journal:  J Pers Med       Date:  2022-05-25

2.  Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect.

Authors:  Sharon L Wong; Nikhil T Awatade; Miro A Astore; Katelin M Allan; Michael J Carnell; Iveta Slapetova; Po-Chia Chen; Jeffry Setiadi; Elvis Pandzic; Laura K Fawcett; John R Widger; Renee M Whan; Renate Griffith; Chee Y Ooi; Serdar Kuyucak; Adam Jaffe; Shafagh A Waters
Journal:  Am J Respir Cell Mol Biol       Date:  2022-07       Impact factor: 7.748

Review 3.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

Review 4.  Nasal Epithelial Cell-Based Models for Individualized Study in Cystic Fibrosis.

Authors:  Duncan E Keegan; John J Brewington
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

5.  CFTR function and clinical response to modulators parallel nasal epithelial organoid swelling.

Authors:  Justin D Anderson; Zhongyu Liu; L Victoria Odom; Latona Kersh; Jennifer S Guimbellot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-19       Impact factor: 6.011

Review 6.  Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease.

Authors:  Andrew Bush; Ian D Pavord
Journal:  Breathe (Sheff)       Date:  2021-09

7.  A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients.

Authors:  Jia Xin Jiang; Leigh Wellhauser; Onofrio Laselva; Irina Utkina; Zoltan Bozoky; Tarini Gunawardena; Zoe Ngan; Sunny Xia; Michelle Di Paola; Paul D W Eckford; Felix Ratjen; Theo J Moraes; John Parkinson; Amy P Wong; Christine E Bear
Journal:  Stem Cell Reports       Date:  2021-10-21       Impact factor: 7.765

Review 8.  Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis.

Authors:  Simon Y Graeber; Constanze Vitzthum; Marcus A Mall
Journal:  J Pers Med       Date:  2021-05-08

Review 9.  CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.

Authors:  Miquéias Lopes-Pacheco
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

10.  Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination.

Authors:  Guido Veit; Ariel Roldan; Mark A Hancock; Dillon F Da Fonte; Haijin Xu; Maytham Hussein; Saul Frenkiel; Elias Matouk; Tony Velkov; Gergely L Lukacs
Journal:  JCI Insight       Date:  2020-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.